Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV
Daniela K van Santen(Burnet Institute), Sara Lodi(Boston University), Rachel Epstein(Boston University), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Mathieu Chalouni(Harvard University), Martin Gisinger(Innsbruck Medical University), Anders Boyd, Bernard Surial(University of Bern), Marina B. Klein(Royal Victoria Regional Health Centre), Jim Young(McGill University), Christopher T. Rentsch(University of London), Juan Berenguer(Instituto de Salud Carlos III), Inmaculada Jarrín(Instituto de Salud Carlos III), Olivier Leleux(Université de Bordeaux), Camille Gilbert, Sophia M. Rein(Harvard University), Robert Zangerle(Universität Innsbruck), José M. Miró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), M. John Gill(University of Calgary), Giota Touloumi(National and Kapodistrian University of Athens), Jessie Torgersen(Center for Clinical Research (United States)), Miguel A. Hernán(Harvard University), Andri Rauch(University of Bern), Antonios Papadopoulos(National and Kapodistrian University of Athens), David Nunes(Boston University), Marc van der Valk(Academic Medical Center), Roger Logan(Harvard University), Antonella d'Arminio Monforte(University of Milan), Linda Wittkop(Université de Bordeaux)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k